ENSIGN GROUP, INC
The Ensign Group is a holding company whose independent subsidiaries provide skilled nursing, senior living and rehabilitative care, along with ancillary services such as mobile diagnostics and medical transportation. It serves patients needing short- or long-term nursing care, seniors seeking residential accommodations and assistance, and healthcare operators that lease its properties. As of December 31, 2025, its services are offered through 373 skilled nursing and senior living facilities in 17 states. Ensign has two reportable segments: skilled services, covering skilled nursing facilities and rehabilitation therapy, and Standard Bearer, which acquires and leases healthcare properties to its subsidiaries and third-party operators. The company earns service payments from Medicaid, Medicare, managed care, commercial insurance and private-pay customers, and rental income from property leases. Its other operations include senior living, mobile diagnostics and transportation. Ensign is headquartered in San Juan Capistrano, California.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Ensign Group (ENSG) reported Q3 earnings with revenue of $1.48B (+14.5%) and EPS of $1.76 (+23.9%). The company raised 2026 guidance, highlighting growth in occupancy, skilled-mix revenue, and clinical outcomes. Acquisitions added 2,370 beds, but Florida and Texas operations face turnaround challenges.
Ensign Group (ENSG) reported strong Q3 results. RBC highlights positive outlook due to Florida expansion. Financial details not specified.
Diversified Healthcare Trust (DHC) reported Q3 2026 results with a net loss of $0.21 per share, missing estimates. Shares fell 2.58% to $7.54. The SHOP segment saw a 50.4% NOI increase, while medical office and life science faced challenges. DHC raised same-property NOI guidance but lowered EBITDAre and FFO guidance due to management fees. The company has $260.7M in liquidity and a debt-to-EBITDAre ratio of 8.2x.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning ENSG (ENSIGN GROUP, INC). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent ENSG coverage spans earnings and financial news.
In the last 30 days, ENSG insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($18K). The most active reporter was Parkinson Mark Vincent with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Guidance raise suggests modest upside, but the information is already public, limiting market reaction.
Strong Q3 results plus an expansion outlook can support bullish positioning, but the article body provided is truncated so the magnitude and guidance details are not verifiable here.
The Ensign lease deal is a new, asset-level revenue stream for ENSG, though the article does not quantify ENSG’s broader financial impact.
Analyst upgrade suggests upside potential.
Analyst upgrade with higher price target may lift the stock.
AlphAI scores every news story that mentions ENSG with an AI model for sentiment and relevance, and aggregates insider trades from ENSIGN GROUP, INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Ensign Group (ENSG) reported Q3 earnings with revenue of $1.48B (+14.5%) and EPS of $1.76 (+23.9%). The company raised 2026 guidance, highlighting growth in occupancy, skilled-mix revenue, and clinical outcomes. Acquisitions added 2,370 beds, but Florida and Texas operations face turnaround challenges.
Ensign Group (ENSG) reported strong Q3 results. RBC highlights positive outlook due to Florida expansion. Financial details not specified.
Diversified Healthcare Trust (DHC) reported Q3 2026 results with a net loss of $0.21 per share, missing estimates. Shares fell 2.58% to $7.54. The SHOP segment saw a 50.4% NOI increase, while medical office and life science faced challenges. DHC raised same-property NOI guidance but lowered EBITDAre and FFO guidance due to management fees. The company has $260.7M in liquidity and a debt-to-EBITDAre ratio of 8.2x.
RBC Capital maintained its Outperform rating on Ensign Group and increased its price target to $239 from $228, suggesting a 33.5% upside from the Nov 2 close of $179.06. Recent analyst price targets for the company range from $210 to $240.
UBS kept its Buy rating on Ensign Group and increased its price target to $240 from $230, suggesting a 30.4% upside from the Oct 28 close of $184.11, according to the firm.
Truist Securities kept Ensign Group at Hold but raised its price target to $210 from $207, suggesting a 14.1% upside from the last close of $184.11.
Oppenheimer reaffirmed its Outperform rating for Ensign Group and increased its price target to $215 from $210, suggesting a 16.8% upside from the Oct 28 close. The firm cited the company's performance in its updated outlook.
Ensign Group reported Q3 2026 revenue of $1.48B, up 14.5% YoY, and EPS of $1.76. Adjusted EPS rose 23.8%. The company raised its 2026 EPS guidance to $7.94–$8.02. Occupancy rates and quality measures improved, and the company expanded its portfolio with 22 new operations.
ENSIGN GROUP, INC (ENSG) filed an SEC Form 8-K — Results of Operations and Financial Condition. The Ensign Group Reports Third Quarter 2026 Results; Raises 2026 Annual Earnings Guidance Conference Call and Webcast scheduled for tomorrow, October 28, 2026 at 10:00 am PT SAN JUAN CAPISTRANO, California – October 27, 2026 – The Ensign Group, Inc. (Nasdaq: ENSG), the parent com
Ensign Group (ENSG) reports Q3 earnings, with expectations of $1.75 EPS on $1.49B revenue. The company has raised guidance twice this year, but stock has not moved. Investors focus on core growth absorbing 20 low-occupancy acquisitions. Full-year outlook is $7.75-$7.85 EPS on $5.87B-$5.92B revenue. Margins and occupancy trends are key metrics.
